An online petition started by Iowa resident Amanda Bonello urging the FDA to support compounding alternatives for weight loss drugs has garnered over 14,000 signatures in just one month. Bonello created the petition in response to proposed limits on weight loss drugs that could potentially impact availability and affordability. Compound pharmacies have been a crucial source of these medications for individuals like Bonello who cannot afford the high costs of name-brand drugs.
The petition has been backed by individuals who have found success and affordability with compounded versions of weight loss medications like semaglutide and tirzepatide. However, pharmaceutical companies are lobbying the FDA to restrict the availability of compounded alternatives, citing concerns about potential impact on the industry. Telehealth provider Balanced Hormone Health in Iowa has treated thousands of clients with compounded GLP-1, emphasizing the cleanliness and effectiveness of compounded products over their name-brand counterparts.
An FDA update on requests to restrict compounded versions of weight loss drugs is anticipated on Friday, with concerns about access to affordable treatment options for individuals facing weight management challenges.
Source
Photo credit www.weareiowa.com